Eledon Pharmaceuticals (ELDN) Equity Average (2014 - 2026)
Eledon Pharmaceuticals posted quarterly Equity Average of $62.9 million for Q1 2026, up 3.72% year-on-year from $60.7 million in Q1 2025, and up 8.08% on a QoQ basis from $58.2 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 13 years of Equity Average data on file, last reported at $62.9 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average rose 3.72% year-over-year to $62.9 million; the trailing twelve-month figure through Mar 2026 stood at $62.9 million (up 3.72% YoY), and the FY2025 full-year result was $71.8 million, up 928.16% from the prior year.
- Equity Average for Q1 2026 stood at $62.9 million, up from $58.2 million in the prior quarter.
- Across five years, Equity Average topped out at $160.2 million in Q1 2022 and bottomed at -$67.3 million in Q2 2024.
- The 5-year median for Equity Average is $54.6 million (2025), against an average of $50.3 million.
- Peak annual rise in Equity Average reached 742.49% in 2024, while the deepest fall reached 220.62% in 2024.
- A 5-year view of Equity Average shows it stood at $82.4 million in 2022, then tumbled by 107.82% to -$6.4 million in 2023, then surged by 742.49% to $41.4 million in 2024, then soared by 40.62% to $58.2 million in 2025, then advanced by 8.08% to $62.9 million in 2026.
- The last three Equity Average figures came in at $62.9 million (Q1 2026), $58.2 million (Q4 2025), and $42.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 62.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.92 Mn |
| Dec 31, 2025 | 58.22 Mn |
| Sep 30, 2025 | 42.85 Mn |
| Jun 30, 2025 | 54.61 Mn |
| Mar 31, 2025 | 60.67 Mn |
| Dec 31, 2024 | 41.41 Mn |
| Sep 30, 2024 | -21.92 Mn |
| Jun 30, 2024 | -67.31 Mn |
| Mar 31, 2024 | -59.45 Mn |
| Dec 31, 2023 | -6.44 Mn |
| Sep 30, 2023 | 39.68 Mn |
| Jun 30, 2023 | 59.28 Mn |
| Mar 31, 2023 | 49.29 Mn |
| Dec 31, 2022 | 82.44 Mn |
| Sep 30, 2022 | 145.24 Mn |
| Jun 30, 2022 | 152.85 Mn |
| Mar 31, 2022 | 160.16 Mn |
| Dec 31, 2021 | 167.37 Mn |
| Sep 30, 2021 | 174.63 Mn |
| Jun 30, 2021 | 181.20 Mn |
| Mar 31, 2021 | 187.23 Mn |
| Dec 31, 2020 | 106.05 Mn |
| Sep 30, 2020 | 15.43 Mn |
| Jun 30, 2020 | 10.55 Mn |
| Mar 31, 2020 | 10.61 Mn |
| Dec 31, 2019 | 11.42 Mn |
| Sep 30, 2019 | 14.70 Mn |
| Jun 30, 2019 | 12.98 Mn |
| Mar 31, 2019 | 12.21 Mn |
| Dec 31, 2018 | 16.41 Mn |
| Sep 30, 2018 | 19.92 Mn |
| Jun 30, 2018 | 22.91 Mn |
| Mar 31, 2018 | 21.88 Mn |
| Dec 31, 2017 | 20.04 Mn |
| Sep 30, 2017 | 22.03 Mn |
| Jun 30, 2017 | 23.40 Mn |
| Mar 31, 2017 | 10.33 Mn |
| Dec 31, 2016 | 13.78 Mn |
| Sep 30, 2016 | 34.57 Mn |
| Jun 30, 2016 | 45.15 Mn |
| Mar 31, 2016 | 27.09 Mn |
| Dec 31, 2015 | 37.34 Mn |
| Sep 30, 2015 | 77.32 Mn |
| Jun 30, 2015 | 86.82 Mn |
| Mar 31, 2015 | 97.20 Mn |
| Dec 31, 2014 | 102.56 Mn |